Evolent Health预计2027年营收同比增长超25%,调整后EBITDA中点值不低于1.5亿美元

美股速递
Aug 06

Evolent Health公司近日发布展望,预计到2027年,其营收将较2026年实现超过25%的增幅。同时,该公司还预期调整后EBITDA(息税折旧摊销前利润)的中点值将达到或超过1.5亿美元。这一财务指引凸显了其对未来业务扩张和盈利能力的信心。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10